Bladder Cancer
Point-Based Prediction Model for Bladder Cancer Risk in Diabetes: A Random Survival Forest-Guided Approach.
January 15, 2025
Immediate second resection versus restage transurethral resection of bladder tumor: A prospective randomized clinical trial (IMMERSE trial).
January 15, 2025
Gemcitabine and docetaxel for high-risk non-muscle-invasive bladder cancer: EuroGemDoce group results.
January 14, 2025
Clinical Outcomes With Immune Checkpoint Inhibitors in Patients With FGFR2/3, MTAP or ERBB2 Genomic Alterations in Advanced Urothelial Carcinoma.
January 14, 2025
Treatment of metastatic urothelial carcinoma in the United Kingdom, France, Germany, Italy, and Spain.
January 13, 2025
Integrating gene therapy into the treatment paradigm for non-muscle invasive bladder cancer.
January 10, 2025
Outcomes of Bladder-Preserving Radiation Therapy in Locally Advanced MIBC - Expert Commentary
January 9, 2025
PD-L1 expression in high-risk non-muscle invasive bladder cancer is not a biomarker of response to BCG.
January 8, 2025